These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [So-called primary (idiopathic) osteomyelofibrosis/-sclerosis (OMF) within the scope of chronic myeloproliferative diseases. II. Course and therapy in 102 patients with special reference to early hyperplastic and advanced fibrosclerotic stages]. Zankovich R; Thiele J; Mödder B; Steinberg T; Simon KG; Fischer R; Diehl V Med Klin (Munich); 1988 Oct; 83(19):629-36. PubMed ID: 3185421 [No Abstract] [Full Text] [Related]
4. Mechanism of myelofibrosis in chronic myeloproliferative disorders. Yonekura S Tokai J Exp Clin Med; 1987 Sep; 12(3):141-5. PubMed ID: 3331217 [No Abstract] [Full Text] [Related]
5. [Bone marrow fibrosis in malignant hemopathies and cancers. Histological study of 2 786 biopsies (author's transl)]. Duhamel G; Stachowiak J Sem Hop; 1981 Jan 18-25; 57(3-4):111-6. PubMed ID: 6261348 [TBL] [Abstract][Full Text] [Related]
6. Management of myelofibrosis--where next? Qureshi M; Harrison C Expert Opin Pharmacother; 2011 Jul; 12(10):1453-5. PubMed ID: 21651445 [No Abstract] [Full Text] [Related]
7. Myelofibrosis in myeloproliferative disorders. Srinivasan U; Talvalkar GV; Advani SH Indian J Cancer; 1978 Sep; 15(3):37-43. PubMed ID: 294411 [No Abstract] [Full Text] [Related]
9. [Role of PDGF on myeloproliferative disorders]. Kimura A; Katoh O; Kuramoto A Rinsho Ketsueki; 1988 Jul; 29(7):989-93. PubMed ID: 3184485 [No Abstract] [Full Text] [Related]
10. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases. Orazi A Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881 [TBL] [Abstract][Full Text] [Related]
11. Myelofibrosis in the myeloproliferative disorders. Ellis JT; Peterson P Prog Clin Biol Res; 1984; 154():19-42. PubMed ID: 6382293 [TBL] [Abstract][Full Text] [Related]
13. Mast cell burden and reticulin fibrosis in the myeloproliferative neoplasms: a computer-assisted image analysis study. Ahmed A; Powers MP; Youker KA; Rice L; Ewton A; Dunphy CH; Chang CC Pathol Res Pract; 2009; 205(9):634-8. PubMed ID: 19446406 [TBL] [Abstract][Full Text] [Related]
14. Transplant decision-making strategies in the myeloproliferative disorders. Fruchtman SM Semin Hematol; 2003 Jan; 40(1 Suppl 1):30-3. PubMed ID: 12682880 [TBL] [Abstract][Full Text] [Related]
15. Bone marrow fibrosis in myeloproliferative neoplasms-associated myelofibrosis: deconstructing a myth? Barosi G; Gale RP Leuk Res; 2011 May; 35(5):563-5. PubMed ID: 21296418 [TBL] [Abstract][Full Text] [Related]
16. Idiopathic myelofibrosis. Clinical aspects and studies on extracellular matrix metabolism. Hasselbalch HC Dan Med Bull; 1993 Mar; 40(1):39-55. PubMed ID: 8472598 [No Abstract] [Full Text] [Related]
17. [Nosology of myeloproliferative disorders]. Stobbe H Z Gesamte Inn Med; 1980 May; 35(9):357-60. PubMed ID: 6933760 [TBL] [Abstract][Full Text] [Related]
18. Pathogenesis of myelofibrosis with myeloid metaplasia: Insight from mouse models. Chagraoui H; Wendling F; Vainchenker W Best Pract Res Clin Haematol; 2006; 19(3):399-412. PubMed ID: 16781480 [TBL] [Abstract][Full Text] [Related]
19. The myelodysplastic syndromes and myeloproliferative disorders. Williams JL Clin Lab Sci; 2004; 17(4):223-34. PubMed ID: 15559729 [TBL] [Abstract][Full Text] [Related]